TO REPORT FRAUD CALL
0800 101 999
TOLL FREE

News Highlights

Public Alert - Counterfeit Cancer Medicine (Sutent)

Wednesday, 9th August 2017

National Drug Authority (NDA) informs health service providers and the public that it has impounded some unregistered and counterfeit medicines; Sutent (sunitinib malate) tablets packed in plastic jar on the market that bears the following features:

Sutent 12.5mg , Batch no : NC 1060 Expiry date : 02/2019

Public Alert - Counterfeit Cancer Medicine (Avastin)

Wednesday, 9th August 2017

National Drug Authority (NDA) informs health serviceproviders and the public that it has impounded some unregistered andcounterfeit medicines; Avastin (Bevacizumab) tablets packed in plastic jar on the market that bears the following features:

Avastin 400mg, Batch no : NC 2001 Expiry date : 02/2019

Service Delivery Timelines now available

Thursday, 3rd August 2017

Special Notice on date Commencement of 12 percent Verification Fees on the list of selected medicines

Thursday, 13th July 2017

National Drug Authority (NDA) informs all pharmaceutical importers that the verification fees for imports of medicine consignments by a licensed person for wholesale or retail which is comprised in the list of selected drugs below in the Amendment to the Fees Rules 2017, shall come into force on the 14th day of July 2017

List of unlicensed pharmacies

Monday, 19th June 2017

Postinor2 Counterfeit Alert

Tuesday, 13th June 2017

This is to inform you that there is counterfeit Postinor2 circulating on the Ugandan market  with the following details.

Batch No T62788B Manufacturing date: 02/20/2016 Expiry date:02/2021

Batch no. T5934T Manufacturing date: 09/2015 Expiry date: 09/2020

Drugs disguised as cosmetics

Monday, 12th June 2017

On the 7th of June 2017, the Executive Director of National Drug Authority (NDA) Ms. Donna Kusemererwa and the Head of Inspectorate services, Mr. Nahamya David paid a courtesy visit to the office of the Commissioner Customs to discuss the now disturbing issue of the swelling importation of concealed drugs (cosmetics).

Public Notice on Medicines Labelling

Tuesday, 16th May 2017

NDA informs health care providers and the general public against using imported medicines which are not labelled or translated in English. Any person involved in the sale and/or dispensing of such illegal products will be prosecuted in accordance with the Law.

NDA Head Quarters relocated

Wednesday, 3rd May 2017

Effective 1st May 2017, NDA Head Quarters relocated from plot 46-48 Lumumba Avenue to Rumee Towers located on Plot 19, Lumumba Avenue (Opposite TWED Plaza). Any inconveniences caused during the process of settling in the new premises is highly regrettable.

NDA Offices relocating

Tuesday, 18th April 2017

With effect from 1st May 2017, NDA Headquarters will operate from First floor of Rumee Towers located on Plot 19, Lumumba Avenue

Public Notice on Anti-Malarial products

Monday, 27th March 2017